Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Sales	$ 4,915,240	$ 635,789
Cost of sales	(1,211,799)	(726,686)
Gross profit (loss)	3,703,441	(90,897)
Operating Expenses
Selling and marketing	580,850	320,768
General and administrative	5,389,716	4,814,312
Depreciation and amortization	145,653	170,189
Gain from insurance settlement		(30,240)
Total operating expenses	6,116,219	5,275,029
Loss From Operations	(2,412,778)	(5,365,926)
Other Expense (Income)
Interest expense, net	348,098	245,174
Forgiveness of PPP loan	(242,486)
Loss on extinguishment of debt		355,602
Gain on debt restructuring		(130,421)
Other income	(162,500)	(2,100)
Losses (gains) from foreign currency translation	33,128	(52,498)
Total other (income) expense	(23,760)	415,757
Net Loss	(2,389,018)	(5,781,683)
Net loss attributable to non-controlling interest	197,312	133,162
Series B preferred stock dividends		(721,752)
Net Loss Attributable to Common Stockholders	$ (2,191,706)	$ (6,370,273)
Net Loss Per Common Share
Basic and Diluted	$ (0.27)	$ (1.48)
Weighted Average Number of Common Shares Outstanding
Basic and Diluted	8,019,206	4,310,440